Welcome
Welcome to the Research Data Platform of the Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ). This site is currently under construction.
Scientific Profile
In April 2024, the Else Kröner Fresenius Foundation approved and funded a proposal to establish a new interdisciplinary Else Kröner Fresenius Center for Optogenetic Therapies. The goal of this center is to harness the great potential of optogenetics – the control of cells with light via light-sensitive proteins (opsins) – for clinical use. Optogenetics enables spatially confined, cell-type-specific control of organs and promises a transformative improvement of clinical care beyond that provided by conventional electrical medical devices for a wide range of patients.